1 IF D H HT T 100 - 100 1 i T 1 Pgiam/iStock via Getty Images Investment update Following my last publication on Dr. Reddy's Laboratories Limited (NYSE:RDY), the stock has advanced another 29% to the upside. Shares are now +20% this year to date, and there are now multiple additional tailwinds adding to the business momentum. These include 1) the company's Q1 FY'25 numbers and 2) the legislative tailwinds made possible by the Affordable Prescriptions for Patients Act passed in the US Senate in July '24. I c ...